Variant report
Variant | nsv598938 |
---|---|
Chromosome Location | chr5:91377829-91407716 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:54)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr5:91395579-91395597 | GM10248 | blood: | n/a | n/a |
2 | CTCF | chr5:91378200-91378350 | BE2_C | brain: | n/a | n/a |
3 | CTCF | chr5:91397958-91398019 | GM20000 | blood: | n/a | n/a |
4 | CTCF | chr5:91399960-91400110 | AG10803 | skin: | n/a | n/a |
5 | CTCF | chr5:91396700-91396778 | LNCaP | prostate: | n/a | n/a |
6 | CTCF | chr5:91396697-91396782 | GM20000 | blood: | n/a | n/a |
7 | EP300 | chr5:91381949-91382245 | SK-N-SH_RA | brain: | n/a | n/a |
8 | EP300 | chr5:91377741-91378383 | SK-N-SH | brain: | n/a | chr5:91378084-91378098 |
9 | EP300 | chr5:91377802-91378290 | SK-N-SH_RA | brain: | n/a | chr5:91378084-91378098 |
10 | EP300 | chr5:91381947-91382253 | SK-N-SH_RA | brain: | n/a | n/a |
11 | EP300 | chr5:91377733-91378326 | SK-N-SH_RA | brain: | n/a | chr5:91378084-91378098 |
12 | FOXA1 | chr5:91378085-91378409 | T-47D | breast: | n/a | n/a |
13 | FOXA1 | chr5:91377978-91378347 | T-47D | breast: | n/a | n/a |
14 | JUN | chr5:91403094-91403135 | HepG2 | liver: | n/a | n/a |
15 | JUN | chr5:91395045-91395217 | HepG2 | liver: | n/a | chr5:91395095-91395108 |
16 | JUND | chr5:91403007-91403278 | HepG2 | liver: | n/a | chr5:91403133-91403140 chr5:91403131-91403142 chr5:91403133-91403141 chr5:91403136-91403143 |
17 | JUND | chr5:91395024-91395213 | HepG2 | liver: | n/a | n/a |
18 | MAFF | chr5:91396295-91396434 | HepG2 | liver: | n/a | n/a |
19 | MAFF | chr5:91402688-91402991 | K562 | blood: | n/a | chr5:91402819-91402837 |
20 | MAFF | chr5:91402644-91402993 | HepG2 | liver: | n/a | chr5:91402819-91402837 |
21 | MAFK | chr5:91396233-91396512 | HepG2 | liver: | n/a | chr5:91396372-91396389 chr5:91396376-91396392 |
22 | MAFK | chr5:91402659-91403007 | IMR90 | lung: | n/a | chr5:91402820-91402835 |
23 | MAFK | chr5:91402618-91403009 | HepG2 | liver: | n/a | chr5:91402820-91402835 |
24 | MAFK | chr5:91393321-91393614 | HepG2 | liver: | n/a | n/a |
25 | MAFK | chr5:91402730-91402974 | Hela-S3 | cervix: | n/a | chr5:91402820-91402835 |
26 | MAFK | chr5:91402641-91403008 | HepG2 | liver: | n/a | chr5:91402820-91402835 |
27 | MAFK | chr5:91402770-91402970 | H1-hESC | embryonic stem cell: | n/a | chr5:91402820-91402835 |
28 | MAFK | chr5:91393357-91393565 | HepG2 | liver: | n/a | n/a |
29 | MAFK | chr5:91402663-91402945 | K562 | blood: | n/a | chr5:91402820-91402835 |
30 | MAFK | chr5:91396265-91396498 | IMR90 | lung: | n/a | chr5:91396372-91396389 chr5:91396376-91396392 |
31 | MAFK | chr5:91396286-91396486 | HepG2 | liver: | n/a | chr5:91396372-91396389 chr5:91396376-91396392 |
32 | MAZ | chr5:91401778-91401879 | HepG2 | liver: | n/a | n/a |
33 | PBX3 | chr5:91381898-91382324 | SK-N-SH | brain: | n/a | n/a |
34 | POLR2A | chr5:91388005-91388484 | H1-neurons | neurons: | n/a | n/a |
35 | POLR2A | chr5:91387932-91388508 | H1-neurons | neurons: | n/a | n/a |
36 | POLR2A | chr5:91378761-91378779 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr5:91399145-91399322 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr5:91406632-91406695 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr5:91399885-91400333 | H1-neurons | neurons: | n/a | n/a |
40 | POLR2A | chr5:91392986-91393127 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr5:91390886-91391078 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chr5:91401645-91401780 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | POLR2A | chr5:91399867-91400450 | H1-neurons | neurons: | n/a | n/a |
44 | POLR2A | chr5:91402818-91402973 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | RAD21 | chr5:91377862-91378210 | SK-N-SH_RA | brain: | n/a | n/a |
46 | REST | chr5:91388017-91388609 | H1-neurons | neurons: | n/a | n/a |
47 | REST | chr5:91387787-91388675 | H1-neurons | neurons: | n/a | n/a |
48 | STAT3 | chr5:91402051-91402111 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | STAT3 | chr5:91390638-91390893 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | TCF12 | chr5:91381903-91382350 | SK-N-SH | brain: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:91404571..91406524-chr5:91570041..91571594,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GPR98-5 | chr5:91378414-91378637 | XLOC_004470 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250049 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7721589 | chr5:91377829-91377830 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs544769608 | chr5:91377870-91377871 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs150793068 | chr5:91377916-91377917 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs578015444 | chr5:91377939-91377940 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs113855276 | chr5:91377944-91377945 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs560483083 | chr5:91377949-91377950 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs571384809 | chr5:91378009-91378010 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs187728583 | chr5:91378022-91378023 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs548536270 | chr5:91378041-91378042 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs7735396 | chr5:91378081-91378082 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs140264177 | chr5:91378120-91378121 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs376445444 | chr5:91378133-91378134 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs530661112 | chr5:91378137-91378138 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs570951665 | chr5:91378148-91378149 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs144211282 | chr5:91378163-91378164 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs192531777 | chr5:91378178-91378179 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs146048287 | chr5:91378191-91378192 | Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs183295370 | chr5:91378216-91378217 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs546211659 | chr5:91378243-91378244 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs566098738 | chr5:91378272-91378273 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs535067771 | chr5:91378277-91378278 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs140079661 | chr5:91378333-91378334 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs569531327 | chr5:91378349-91378350 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs78394796 | chr5:91378360-91378361 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs188791291 | chr5:91378394-91378395 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs578048696 | chr5:91378417-91378418 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs540696057 | chr5:91378420-91378421 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs376376936 | chr5:91378427-91378428 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs376499534 | chr5:91378438-91378439 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs200433667 | chr5:91378473-91378474 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs200852908 | chr5:91378474-91378475 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs398093570 | chr5:91378484-91378485 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs145831642 | chr5:91378581-91378582 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs574109334 | chr5:91378634-91378635 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs543037545 | chr5:91378693-91378694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11444588 | chr5:91378694-91378695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs398109162 | chr5:91378699-91378700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561871984 | chr5:91378760-91378761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192636770 | chr5:91378788-91378789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs77983634 | chr5:91378885-91378886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs78797773 | chr5:91378899-91378900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34549102 | chr5:91379090-91379091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148975016 | chr5:91379167-91379168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568026085 | chr5:91379184-91379185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs4496736 | chr5:91379206-91379207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566208464 | chr5:91379276-91379277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570121276 | chr5:91379308-91379309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs66968264 | chr5:91379336-91379337 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs113803459 | chr5:91379409-91379410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569452277 | chr5:91379422-91379423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:91377200-91378600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:91377600-91378400 | Active TSS | A549 | lung |
3 | chr5:91377800-91378200 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr5:91377800-91378200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr5:91377800-91378200 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr5:91377800-91378200 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr5:91377800-91378200 | Active TSS | Hela-S3 | cervix |
8 | chr5:91377800-91378200 | Active TSS | NHDF-Ad | bronchial |
9 | chr5:91377800-91378200 | Active TSS | Osteobl | bone |
10 | chr5:91377800-91378400 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr5:91378200-91378400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr5:91378200-91378400 | Flanking Active TSS | Hela-S3 | cervix |
13 | chr5:91378200-91378400 | Flanking Active TSS | NHDF-Ad | bronchial |
14 | chr5:91378600-91379800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr5:91399800-91401000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |